Previous close | 234.21 |
Open | 243.02 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 230.51 - 244.25 |
52-week range | 230.51 - 286.33 |
Volume | |
Avg. volume | 3,814 |
Market cap | 630.866M |
Beta (5Y monthly) | 0.46 |
PE ratio (TTM) | 0.37 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its second quarter of fiscal 2024, which ended March 31, 2024.
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per common share, payable on June 28, 2024 to holders of record on June 10, 2024. The indicated annual dividend rate is $3.80 per share.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024 at 11:00 am Eastern Time.